https://orcid.org/0000-0003-1100-101X
Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (23)
Pawan Gupta, Umesh Panwar & Sanjeev Singh. (2024) Novel scaffolds identification against Mpro of SARS-CoV-2 using shape based screening and molecular simulation methods. Chemical Physics Impact, pages 100496.
Crossref
Crossref
Alejandro García-Rudolph, David Sanchez-Pinsach, Dietmar Frey, Eloy Opisso, Katryna Cisek & John D. Kelleher. (2023) Know an Emotion by the Company It Keeps: Word Embeddings from Reddit/Coronavirus. Applied Sciences 13:11, pages 6713.
Crossref
Crossref
Soraiya Ebrahimpour-Koujan, Amir Ali Sohrabpour, Saeid Safari, Nima Baziar, Shima Hadavi, Laleh Payahoo & Samaneh Shabani. (2022) A comprehensive nutritional support perspective in patients with COVID-19: a review. Nutrition & Food Science 53:2, pages 334-357.
Crossref
Crossref
Adekunle Babajide Rowaiye, Akwoba Joseph Ogugua, Doofan Bur, Timipanipiri Wood, Zainab Labbo, Chimaobi Chukwu, Femi Johnson Afolabi, Ezinne Janefrances Nwonu & Tarimoboere Agbalalah. (2023) The Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Agaricomycetes) Can Combat Cytokine Storm and Other COVID-19 Related Pathologies: A Review. International Journal of Medicinal Mushrooms 25:5, pages 1-15.
Crossref
Crossref
Kadri Kangro, Alisa S. Wolberg & Matthew J. Flick. (2022) Fibrinogen, Fibrin, and Fibrin Degradation Products in COVID-19. Current Drug Targets 23:17, pages 1593-1602.
Crossref
Crossref
Emanuela Foglia, Lucrezia Ferrario, Fabrizio Schettini, M. Beatrice Pagani, Martina Dalla Bona & Emanuele Porazzi. (2022) COVID-19 and hospital management costs: the Italian experience. BMC Health Services Research 22:1.
Crossref
Crossref
Amit Goel, Alka Verma, Prachi Tiwari, Harshita Katiyar, Amita Aggarwal, Dheeraj Khetan, Mayank, Ravi V. Krishna Kishore, Pankaj Kumar, Thakur Prashant Singh, Sabreena Sheikh, Manas Vaishnav, Piyush Pathak & Shalimar. (2022) Serological Immune Response Following ChAdOx1 nCoV-19 Vaccine (Covishield®) in Patients with Liver Cirrhosis. Vaccines 10:11, pages 1837.
Crossref
Crossref
Noha D. Fayed, Mona F. Arafa, Ebtesam A. Essa & Gamal M. El Maghraby. (2022) Lopinavir-menthol co-crystals for enhanced dissolution rate and intestinal absorption. Journal of Drug Delivery Science and Technology 74, pages 103587.
Crossref
Crossref
Matthew J. Lees, Nathan Hodson, Cassidy T. Tinline-Goodfellow, Hugo J. W. Fung, Antonis Elia & Daniel R. Moore. (2022) Challenges of rapamycin repurposing as a potential therapeutic candidate for COVID-19: implications for skeletal muscle metabolic health in older persons. American Journal of Physiology-Endocrinology and Metabolism 322:6, pages E551-E555.
Crossref
Crossref
Zijun Wang, Siya Zhao, Yuyi Tang, Zhili Wang, Qianling Shi, Xiangyang Dang, Lidan Gan, Shuai Peng, Weiguo Li, Qi Zhou, Qinyuan Li, Joy James Mafiana, Rafael González Cortés, Zhengxiu Luo, Enmei Liu & Yaolong Chen. (2022) Potentially effective drugs for the treatment of COVID-19 or MIS-C in children: a systematic review. European Journal of Pediatrics 181:5, pages 2135-2146.
Crossref
Crossref
Anamul Hasan, Partha Biswas, Tohmina Afroze Bondhon, Khoshnur Jannat, Tridib K. Paul, Alok K. Paul, Rownak Jahan, Veeranoot Nissapatorn, Tooba Mahboob, Polrat Wilairatana, Md Nazmul Hasan, Maria de Lourdes Pereira, Christophe Wiart & Mohammed Rahmatullah. (2022) Can Artemisia herba-alba Be Useful for Managing COVID-19 and Comorbidities?. Molecules 27:2, pages 492.
Crossref
Crossref
Pradana Zaky Romadhon, Siprianus Ugroseno Yudho Bintoro, Satriyo Dwi Suryantoro, Tri Pudy Asmarawati, Alfian Nur Rosyid, Merlyna Savitri, Putu Niken Ayu Amrita, Muhammad Noor Diansyah, Ami Ashariati Prayoga, Choirina Windradi, Bagus Aulia Mahdi, Krisnina Nurul Widiyastuti, Dwiki Novendrianto, Esthiningrum Dewi Agustin, Firas Farisi Alkaff, Kartika Prahasanti & Didi Darmahadi Dewanto. (2023) Risk of lowering mortality from the improvement of inflammatory markers and disease progression among moderate, severe, and critical COVID-19 patients using anticoagulant : a cross-sectional study from two second referral hospitals in Surabaya, Indonesia. F1000Research 11, pages 61.
Crossref
Crossref
Pradana Zaky Romadhon, Siprianus Ugroseno Yudho Bintoro, Satriyo Dwi Suryantoro, Tri Pudy Asmarawati, Alfian Nur Rosyid, Merlyna Savitri, Putu Niken Ayu Amrita, Muhammad Noor Diansyah, Ami Ashariati Prayoga, Choirina Windradi, Bagus Aulia Mahdi, Krisnina Nurul Widiyastuti, Dwiki Novendrianto, Esthiningrum Dewi Agustin, Firas Farisi Alkaff, Kartika Prahasanti & Didi Darmahadi Dewanto. (2022) Risk of lowering mortality from the improvement of inflammatory markers and disease progression among moderate, severe, and critical COVID-19 patients using anticoagulant : a cross-sectional study from two second referral hospitals in Surabaya, Indonesia. F1000Research 11, pages 61.
Crossref
Crossref
Pradana Zaky Romadhon, Siprianus Ugroseno Yudho Bintoro, Satriyo Dwi Suryantoro, Tri Pudy Asmarawati, Alfian Nur Rosyid, Merlyna Savitri, Putu Niken Ayu Amrita, Muhammad Noor Diansyah, Ami Ashariati Prayoga, Choirina Windradi, Bagus Aulia Mahdi, Krisnina Nurul Widiyastuti, Dwiki Novendrianto, Esthiningrum Dewi Agustin, Firas Farisi Alkaff, Kartika Prahasanti & Didi Darmahadi Dewanto. (2022) The improvement of inflammatory markers and disease progression among moderate, severe, and critical COVID-19 patients: a cross-sectional study from two second referral hospitals in Surabaya, Indonesia. F1000Research 11, pages 61.
Crossref
Crossref
Pradana Zaky Romadhon, Siprianus Ugroseno Yudho Bintoro, Satriyo Dwi Suryantoro, Merlyna Savitri, Putu Niken Ayu Amrita, Muhammad Noor Diansyah, Ami Ashariati Prayoga, Choirina Windradi, Bagus Aulia Mahdi, Krisnina Nurul Widiyastuti, Dwiki Novendrianto, Esthiningrum Dewi Agustin, Firas Farisi Alkaff, Kartika Prahasanti & Didi Darmahadi Dewanto. (2022) The improvement of inflammatory markers and disease progression among moderate, severe, and critical COVID-19 patients: a cross-sectional study from two second referral hospitals in Surabaya, Indonesia. F1000Research 11, pages 61.
Crossref
Crossref
Antonella Minutolo, Vita Petrone, Marialaura Fanelli, Marco Iannetta, Martina Giudice, Ines Ait Belkacem, Marta Zordan, Pietro Vitale, Guido Rasi, Paola Sinibaldi-Vallebona, Loredana Sarmati, Massimo Andreoni, Fabrice Malergue, Emanuela Balestrieri, Sandro Grelli & Claudia Matteucci. (2021) High CD169 Monocyte/Lymphocyte Ratio Reflects Immunophenotype Disruption and Oxygen Need in COVID-19 Patients. Pathogens 10:12, pages 1639.
Crossref
Crossref
Meng-Li Wu, Feng-Liang Liu, Jing Sun, Xin Li, Xiao-Yan He, Hong-Yi Zheng, Yan-Heng Zhou, Qihong Yan, Ling Chen, Guo-Ying Yu, Junbiao Chang, Xia Jin, Jincun Zhao, Xin-Wen Chen, Yong-Tang Zheng & Jian-Hua Wang. (2021) SARS-CoV-2-triggered mast cell rapid degranulation induces alveolar epithelial inflammation and lung injury. Signal Transduction and Targeted Therapy 6:1.
Crossref
Crossref
Katarzyna Papaj, Patrycja Spychalska, Katarzyna Hopko, Patryk Kapica, Andre Fisher, Markus A. Lill, Weronika Bagrowska, Jakub Nowak, Katarzyna Szleper, Martin Smieško, Anna Kasprzycka & Artur Góra. (2021) Investigation of Thiocarbamates as Potential Inhibitors of the SARS-CoV-2 Mpro. Pharmaceuticals 14:11, pages 1153.
Crossref
Crossref
bharti Shilpa. (2021) Herbal Remedies for Covid- 19: Perception and Self-Use. International Journal of pharma and Bio Sciences 12:4, pages 71-81.
Crossref
Crossref
S. Anil Kumar & B.L. Bhaskar. (2021) Preliminary investigation of drug impurities associated with the anti-influenza drug Favipiravir – An insilico approach. Computational and Theoretical Chemistry 1204, pages 113375.
Crossref
Crossref
Massimo Franchini, Fabiana Corsini, Daniele Focosi & Mario Cruciani. (2021) Safety and Efficacy of Convalescent Plasma in COVID-19: An Overview of Systematic Reviews. Diagnostics 11:9, pages 1663.
Crossref
Crossref
Logesh Kumar Selvaraj, Geethanjali Thayumanavan, Srikanth Jeyabalan & Sugin Lal Jabaris. (2021) Molecular Docking Studies of Phytoconstituents Identified in Traditional Siddha Polyherbal Formulations Against Possible Targets of SARS-CoV-2. Journal of Molecular Docking 1:1, pages 15-24.
Crossref
Crossref
Ehab Al-Moubarak, Mohsen Sharifi & Jules C. Hancox. (2021) In silico Exploration of Interactions Between Potential COVID-19 Antiviral Treatments and the Pore of the hERG Potassium Channel—A Drug Antitarget. Frontiers in Cardiovascular Medicine 8.
Crossref
Crossref